// App-Quantinova.ai

1887 : Ten-Year Continued Nonvertebral Fracture Reduction in Postmenopausal Osteoporosis with Denosumab Treatment

Researchers

Presenter

  • S Ferrari

Principal Investigators

  • PW Butler

  • Paul D Miller

  • C Roux

  • AT Wang

  • Rachel B. Wagman

  • EM Lewiecki

Medical Centers

  • DL Kendler

  • Geneva University Hospitals, Geneva, Switzerland

  • Amgen Inc, Thousand Oaks, CA

  • The University of British Columbia, Vancouver, BC, Canada

  • Colorado Center for Bone Research, Lakewood, CO

  • Paris Descartes University, Paris, France

  • New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM

Locations

  • Switzerland

  • United States

  • Canada

  • France

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • N/A

Biomarkers

  • Exostosin Glycosyltransferase 1

Drug/Treatment

  • Denosumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Open Label

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved